BioNTech SE (BNTX) Income from Continuing Operations (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Income from Continuing Operations data on file, last reported at 174373718.5 in Q4 2025.

• For the quarter ending Q4 2025, Income from Continuing Operations fell 147.59% year-over-year to 174373718.5; the trailing twelve-month figure through Dec 2025 stood at 1056780341.98 (down 41.52% YoY), and the FY2025 full-year result was 1090832703.83, down 47.92% from the prior year.
• Income from Continuing Operations slipped to 174373718.5 in Q4 2025, from 91303202.63 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 7221719704.56 in Q3 2021 to a low of 865602233.83 in Q2 2024.
• A 5-year average of 2030780924.39 and a median of 650437586.83 in 2024 frame the typical range for Income from Continuing Operations.
• Across the five-year window, Income from Continuing Operations soared 13561718996.32% in 2021 and tumbled 147.59% in 2025, its largest moves.
• Tracing BNTX's Income from Continuing Operations over 5 years: stood at 7163088507.63 in 2021, then tumbled by 42.08% to 4148835910.98 in 2022, then plunged by 77.48% to 934453810.95 in 2023, then sank by 60.79% to 366421362.72 in 2024, then plunged by 147.59% to 174373718.5 in 2025.
• Business Quant data shows BNTX's Income from Continuing Operations at 174373718.5 in Q4 2025, 91303202.63 in Q3 2025, and 474064717.33 in Q2 2025.